| Document |
Document Title |
|
WO/2019/039509A1 |
A composition comprising: a substance (A) (excluding a metal-organic framework) comprising atoms of at least one metal selected from the group consisting of zinc, cobalt, niobium, zirconium, cadmium, copper, nickel, chromium, vanadium, t...
|
|
WO/2019/022588A2 |
The present invention relates to an antimicrobial agent comprising MOF and an antimicrobial filter comprising the same. The antimicrobial agent and the antimicrobial filter of the present invention may exhibit excellent antimicrobial act...
|
|
WO/2019/013498A1 |
The present application relates to a method for producing a methionine-metal chelate. A methionine-metal chelate produced by a method that involves adding a metal chloride after first reacting Ca(OH)2 and methionine can be widely used as...
|
|
WO/2019/013497A1 |
The present application relates to a method for producing a methionine-metal chelate. A methionine-metal chelate produced by a method that involves adding a metal nitrate after first reacting Ca(OH)2 and methionine can be widely used as ...
|
|
WO/2019/004371A1 |
The purpose of the present invention is to realize a technique for efficiently synthesizing an organic zinc compound without using a toxic reagent and the like that are difficult to handle, and to do so with a small number of steps. This...
|
|
WO/2018/230700A1 |
A dialkoxy magnesium which is characterized in that: the arithmetic mean roughness (Ra) of particle surfaces is 0.5 or less; and the maximum height (Rz) of particle surfaces is 2.0 or less. The present invention is able to provide a dial...
|
|
WO/2018/222785A1 |
Porous calcium lactate metal-organic frameworks (MOFs) comprise non-toxic metal ions - Ca(II) and non-toxic, renewable and cheap linkers - lactate and acetate. The MOFs are nontoxic and environmentally-benign, and can be used as degradab...
|
|
WO/2018/210711A1 |
The present invention relates to silica-based heterogeneous zinc compounds which are suitable as catalysts in the reaction of amines with dialkyl carbonates to produce carbamates. The catalysts have the formula [SiO2]-CH2-CHR-X-COOZn[Y],...
|
|
WO/2018/198096A2 |
Provided herein is a coordination complex of Formula (I): wherein - - - - - is a coordinate bond; where M is a metal; X1, X2, X3, X4, X5, X6, and X7 are each independently selected from a heteroatom; R1, R2, R3, R4, R7, and R8 are each i...
|
|
WO/2018/192686A1 |
The invention relates to a method for producing, amongst other things, amino-acid and/or hydroxycarboxylic-acid metal chelates, a solvent-free mixture of at least one metal oxide, metal hydroxide, metal carbonate or oxalate, and the soli...
|
|
WO/2018/182174A1 |
The present invention relates to a polyolefin-polystyrene multi-block copolymer having a structure comprising a polyolefin block and polystyrene blocks bonded to both ends of the polyolefin block, to an organozinc compound for preparing ...
|
|
WO/2018/162906A1 |
The present invention relates to a process for preparing a magnesium formate based metal-organic framework. The process comprises (a) combining magnesium or magnesium oxide with formic acid; (b) heating the reaction mixture of step (a) a...
|
|
WO/2018/153331A1 |
The invention discloses a biflavone-zinc complex as well as a preparation method therefor and a use thereof. The invention takes amentoflavone as a ligand, zinc ion as a central ion, and amentoflavone-zinc complex is obtained through rea...
|
|
WO/2018/146116A1 |
The present invention relates to in vivo stable 197(m)Hg compounds according to formula (I) for use in nuclear medical diagnostics and endoradionuclide therapy (theranostics), particularly the treatment of cancer, a method for the produc...
|
|
WO/2018/143156A1 |
The present invention pertains to: a solution that contains a diketone compound having an alkoxy group, dialkylzinc represented by general formula (1) and/or a partial hydrolysate of said dialkylzinc, and a solvent; and a method for prod...
|
|
WO/2018/107425A1 |
A composition comprising resin and dye mixture, an article having a polymer layer formed from the composition, and a color filter formed from the composition are developed. The dye mixture contains a phthalocyanine compound and another d...
|
|
WO/2018/104424A1 |
The present invention relates to an organometallic compound of formula (I) or (II) in which M denotes an atom of a metal belonging to the 2nd column of the periodic table; R1, R2, R3 and R4 are hydrogen atoms or alkyl or aryl substituent...
|
|
WO/2018/099698A1 |
The invention relates to a process for the preparation of triaryl-organo borates from boronic ester and the use of these substances in photo initiator systems, photopolymer compositions comprising such photo initiator systems, a holograp...
|
|
WO/2018/091774A1 |
The present application relates to a phthalocyanine, to a method for preparing the phthalocyanine, and to an object coated or impregnated with the phthalocyanine. The present application also relates to a method for providing reactive ox...
|
|
WO/2018/087230A1 |
Compound of formula (4) or formula (5), wherein L is a neutral ligand, preferably a nitrogen-containing heterocyclic carbene (NHC) such as carbene containing at least two nitrogen atoms, a cyclic aminoalkyl carbene (CAAC) or a bicyclic a...
|
|
WO/2018/050515A1 |
The present invention relates to a method for producing halogenated bicyclic compounds of formula (II) starting from compounds of the Q-H structure via intermediate steps of formula (IIIa) or (IIIb) Q-Hal (II), (IIIa), (IIIb), wherein Q ...
|
|
WO/2018/045824A1 |
A manufacturing method based on simultaneous encapsulation of a target substance and synthesis of MOFs having redox activity, comprising: selecting methylene blue as an organic target molecule, and by means of one pot method, encapsulati...
|
|
WO/2018/038025A1 |
Provided is a near infrared light emitting material containing a porphyrin compound that is amorphous and is represented by general formula (I).
|
|
WO/2018/035660A1 |
A porous chiral material of formula [M(L)1.5(A)]+X- wherein M is a metal ion; L is a nitrogen-containing bidentate ligand; A is the anion of mandelic acid or a related acid; and X- is an anion
|
|
WO/2018/021406A1 |
Provided are: a novel metal complex; and an electron-transporting material which uses said metal complex and can be formed by a wet process during the manufacture of an organic electroluminescent device having a multilayer structure. Thi...
|
|
WO/2018/008510A1 |
The present invention addresses the problem of providing: a novel organic magnesium phosphide characterized by having a phosphorus-magnesium bond and a method for producing the organic magnesium phosphide; and a novel organic magnesium p...
|
|
WO/2018/007224A1 |
The present invention relates to a method for preparing halogenated pyridine derivatives of formula (II) starting from compounds of formula (I) via intermediate stages of formula (IIIa) or (IIIb), in which the radicals Q and W independen...
|
|
WO/2018/002941A1 |
Novel processes of preparing block polyester copolymers while precisely controlling the stereoconfiguration (e.g., tacticity), chemical composition and/or length of each unit (block) are provided. Block polyester copolymers featuring des...
|
|
WO/2017/215364A1 |
Provided in the present invention are an acetylacetone metal component, a preparation method therefor, plastic and an application thereof as a heat stabilizer. The acetylacetone metal component has the following general formula: (OH)- xÂ...
|
|
WO/2017/218065A1 |
A MOF production system and method of making are detailed for continuous and controlled synthesis of MOFs and MOF composites. The system can provide optimized yields of MOFs and MOF composites greater than or equal to 95%.
|
|
WO/2017/214546A1 |
In some embodiments, this application relates to inventive compounds (e.g.. Formula (I), Formula (II), thiosemicarbazones and/or thiosemicarbazones and then metal (e.g..zinc, cobalt, nickel, or copper) complexes, and extended structures ...
|
|
WO/2017/205752A1 |
Compositions and methods for adsorption of a species (e.g., ammonia, water, a halogen) comprising metal organic frameworks (MOFs) are generally provided. In some embodiments, a MOF comprises a plurality of metal ions, each coordinated wi...
|
|
WO/2017/204322A1 |
The present invention pertains to a magnesium battery electrolytic solution and the like obtained by mixing a compound represented by general formula (I) below, a Lewis acid or a compound represented by general formula (A) below, and a s...
|
|
WO/2017/200792A1 |
The described invention provides a compound comprising an organometallic complex comprising a core of ruthenium and sphingomyelin, with the option of added zinc, that, in a therapeutic amount, through further connections with contributin...
|
|
WO/2017/178230A1 |
The invention relates to a continuous method for producing Grignard adducts in which magnesium chips are mechanically activated in situ. The invention also relates to a device for carrying out the claimed method.
|
|
WO/2017/164577A1 |
The present invention relates to an organozinc-supported catalyst, a method for producing the same, and a method for preparing a polyalkylene carbonate resin using the catalyst. The organozinc-supported catalyst provided through the pres...
|
|
WO/2017/146420A1 |
The present invention relates to an LED package comprising a red organic-inorganic hybrid light-emitting material and a backlight unit employing the same and, specifically, to an LED package comprising a red organic-inorganic hybrid ligh...
|
|
WO/2017/141003A1 |
A salt of the general formula: Mg2+(Lx)6(PF6 −)2 wherein each L is a ligand selected from dichloromethane, a cyclic ether; or a nitrile of the general formula R−C≡N. The method of making the salt comprises the steps: providing Mg m...
|
|
WO/2016/184652A9 |
The present invention relates to methods for producing metalated organic compounds R1-Met under continuous flow conditions. The invention further relates to the metalated compounds obtained by these methods, and to the further reaction t...
|
|
WO/2017/117189A1 |
A composition, comprising an amidomagnesium chloride represented by the following structural formula R1R2NMgCl, and an amidomagnesium bromide represented by the following structural formula R3R4NMgBr is disclosed. Values and example valu...
|
|
WO/2017/100546A1 |
Methods for preparing compounds having the following structure (I): (Formula (I)) or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof, wherein R1, R2a, R2b, R3a, R3b, R4a, R4b and R4c, are as defined herein are provi...
|
|
WO/2017/098180A1 |
The invention relates to complexing agents of formula (I), in which A1, A2, A3 and R1 are as defined in the description. The invention likewise relates to lanthanide complexes obtained from said complexing agents. The invention can be us...
|
|
WO/2017/091055A1 |
Disclosed are: a method for preparing zinc carboxylate hydrate; zinc carboxylate hydrate prepared thereby; and an antibacterial plastic material containing the zinc carboxylate hydrate. The method for preparing zinc carboxylate hydrate u...
|
|
WO/2017/078609A1 |
The present invention relates to a metal-organic framework with encapsulated target-molecule, a process for the preparation of a metal-organic framework with encapsulated target-molecule, as well as the metal-organic framework with encap...
|
|
WO/2017/058910A1 |
The present disclosure relates to a process for synthesizing multi- or dual- headed compositions having the formula R1MA[R2MA—] NR1 by employing a sterically hindered compound and an organometallic compound in the presence of a transit...
|
|
WO/2017/039528A1 |
The invention relates to carbon dioxide sensing compounds. In particular, present invention relates to said sensing compounds comprising a metal phthalocycanine. Furthermore, the invention relates to the tuning sensitivity of the metal p...
|
|
WO/2017/034491A1 |
The present invention relates to coordination complexes. Compounds of 1-substituted- benzimidazolezinc and cobalt complexes according to the present invention have high level of biological activity.
|
|
WO/2017/029242A1 |
In an example of a method for simultaneously fixing and staining cells, the cells are initially incubated in a solution including a Ln(III)Zn 16 (HA ligand)16 metallacrown complex, wherein the HA ligand is a hydroximate ligand. The incub...
|
|
WO/2017/031173A1 |
Disclosed herein are novel amine-functionalized porphyrin compounds, as wells as pharmaceutically acceptable salts or esters thereof. The disclosed compounds can be used to impart antioxidant, antiinflammatory, anti-microbial, and/or cel...
|
|
WO/2017/026619A1 |
The present invention relates to a preparation of a magnesium metal-organic framework and an amine-functionalization thereof. More specifically, a metal-organic framework, as a porous solid having crystallinity, has an adjustable pore si...
|
